These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 4921577

  • 1. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T, Atsumi T, Isokane N, Yamashita S, Sano T.
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract] [Full Text] [Related]

  • 2. [Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography].
    Motomiya T.
    Nihon Naika Gakkai Zasshi; 1970 Feb 10; 59(2):117-25. PubMed ID: 4910199
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T, Motomiya T, Isokane N, Shimamoto T.
    Jpn Heart J; 1971 Jul 10; 12(4):335-46. PubMed ID: 5314713
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA, Fajardo JD, Velles Aguirre L, Quijano E, Ciliberti E, Lucarelli R.
    Prensa Med Argent; 1970 Apr 24; 57(8):394-8. PubMed ID: 5517707
    [No Abstract] [Full Text] [Related]

  • 7. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA, Belousov IuB, Martynov AI, Koroleva SA, Zimin VS.
    Kardiologiia; 1972 Nov 24; 12(11):39-45. PubMed ID: 4655879
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
    Walton KW, Craig GM, Prior P, Waterhouse JA, Skilton J.
    Br Heart J; 1973 Feb 24; 35(2):211-9. PubMed ID: 4570447
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].
    Heisig N, Westermann KW, Stolterfoht CA, Zaki J.
    Med Klin; 1970 Dec 25; 65(52):2289-93. PubMed ID: 5522670
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 13. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T, Atsumi T.
    Jpn Heart J; 1965 Sep 27; 6(5):407-15. PubMed ID: 5294603
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical tests using pyridinol carbamate on the arterial circulation and blood coagulation in patients with arteriosclerosis obliterans].
    De Soldati L, Castro CM, Grilli H, Reussi J.
    Prensa Med Argent; 1969 May 23; 56(12):546-53. PubMed ID: 5343928
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Failure of vasodilator drugs in arteriosclerosis obliterans.
    Coffman JD, Mannick JA.
    Ann Intern Med; 1972 Jan 23; 76(1):35-9. PubMed ID: 4553743
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep 23; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov 23; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.